PTX3 and type 2 diabetes mellitus: Bala et al. [80] conducted a study involving a total of 80 patients with T2DM who had been treated with insulin for at least six months, aiming to assess the relationship between insulin dose and inflammatory and oxidative stress markers, including PTX3.